Symbol="XENE"
AssetType="Common Stock"
Name="Xenon Pharmaceuticals Inc"
Description="Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada."
CIK="1582313"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 - 3650 GILMORE WAY, BURNABY, BC, CA"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="2487210000"
EBITDA="-184304992"
PERatio="None"
PEGRatio="-0.06"
BookValue="10.15"
DividendPerShare="0"
DividendYield="0"
EPS="-2.53"
RevenuePerShareTTM="0.002"
ProfitMargin="0"
OperatingMarginTTM="-1410.11"
ReturnOnAssetsTTM="-0.156"
ReturnOnEquityTTM="-0.229"
RevenueTTM="132000"
GrossProfitTTM="-96333000"
DilutedEPSTTM="-2.53"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="52.64"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="181.44"
PriceToBookRatio="3.217"
EVToRevenue="136.05"
EVToEBITDA="-16.41"
Beta="1.385"
num_52WeekHigh="43.75"
num_52WeekLow="31.79"
num_50DayMovingAverage="38.11"
num_200DayMovingAverage="37.9"
SharesOutstanding="64146000"
DividendDate="None"
ExDividendDate="None"
symbol="XENE"
open="38.73"
high="39.18"
low="38.00"
price="38.88"
volume="381583.00"
latest_trading_day="2023-08-30"
previous_close="38.57"
change="0.31"
change_percent="0.8037%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="353548"
Change_recent_avg="0.04"
Delta_recent_avg="1.37"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0195.jpeg"
image_negative_thumbnail_id_2="1129"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0162.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
